Abiraterone in Metastatic Prostate Cancer
Vložit
- čas přidán 13. 12. 2015
- The panelists, Raoul S. Concepcion, MD, FACS; Michael Fabrizio, MD, FACS; Jorge A. Garcia, MD, FACP; Charles J. Ryan, MD; and Judd W. Moul, MD, FACS, elaborate on the use of abiraterone, an androgen synthesis inhibitor, in metastatic prostate cancer.
What about the people that don't have the money?!
En español